Related Experiment Video
Updated: May 29, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs
Tsutomu Suzuki1, Asuteka Nagao, Takeo Suzuki
1Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo, Tokyo, Japan. ts@chembio.t.u-tokyo.ac.jp
Abstract:
Mitochondrial DNA mutations that cause mitochondrial dysfunction are responsible for a wide spectrum of human diseases, referred to as mitochondrial diseases. Pathogenic point mutations are found frequently in genes encoding mitochondrial (mt) tRNAs, indicating that impaired functioning of mutant mt tRNAs is the primary cause of mitochondrial dysfunction. Our previous studies revealed the absence of posttranscriptional taurine modification at the anticodon wobble uridine in mutant mt tRNAs isolated from cells derived from patients with two major classes of mitochondrial diseases, MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) and MERRF (myoclonus epilepsy associated with ragged red fibers). Defective taurine modification of the mutant mt tRNAs results in a deficiency in protein synthesis as the cognate codons of the mutant mt tRNA cannot be decoded. These findings represent the first evidence of a molecular pathogenesis caused by an RNA modification disorder.
Insights
Mitochondrial diseases stem from faulty mitochondrial DNA. Taurine modification defects in mitochondrial tRNAs impair protein synthesis, revealing a novel RNA modification disorder as a cause of these conditions.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Mitochondrial diseases arise from mitochondrial DNA mutations causing dysfunction.
- Pathogenic mutations often affect mitochondrial transfer RNAs (mt tRNAs), leading to impaired function.
- Previous research linked specific mutations to mitochondrial diseases like MELAS and MERRF.
Purpose of the Study:
- To investigate the molecular pathogenesis of mitochondrial diseases caused by mt tRNA mutations.
- To determine the role of posttranscriptional taurine modification in mutant mt tRNAs.
- To establish the link between impaired RNA modification and mitochondrial dysfunction.
Main Methods:
- Analysis of mt tRNAs isolated from patient-derived cells.
- Assessment of posttranscriptional taurine modification at the anticodon wobble uridine.
- Evaluation of protein synthesis efficiency in relation to mt tRNA function.
Main Results:
- Absence of taurine modification was observed in mutant mt tRNAs from MELAS and MERRF patients.
- Defective taurine modification leads to decoding errors of cognate codons.
- Impaired mt tRNA function results in a deficiency in mitochondrial protein synthesis.
Conclusions:
- The study identifies a deficiency in taurine modification of mt tRNAs as a primary cause of mitochondrial dysfunction.
- This represents the first evidence of molecular pathogenesis linked to an RNA modification disorder.
- Restoring taurine modification could be a therapeutic strategy for mitochondrial diseases.
More Related Videos
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
Published on: November 23, 2011
07:32Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
Published on: February 9, 2020
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
ATP Synthase: Mechanism
Animal Mitochondrial Genetics
Inborn Errors of Metabolism
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...